The Department, taking into consideration the recommendations of its Prescription Monitoring Program Advisory Committee, may issue a rule scheduling a substance in Schedule IV if it finds that:
(1) the substance has a low potential for abuse relative to substances in Schedule III;(2) the substance has currently accepted medical use in treatment in the United States; and(3) abuse of the substance may lead to limited physiological dependence or psychological dependence relative to the substances in Schedule III.Amended by P.A. 097-0334,§ 5, eff. 1/1/2012.